PTP pi/PTPRU Antibody (PTPRU/7616) [PE]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-24115PE
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Immunohistochemistry-Paraffin
Label
PE (Excitation = 488 nm, Emission = 575 nm)
Antibody Source
Monoclonal Mouse IgG2 kappa Clone # PTPRU/7616
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for PTP pi/PTPRU Antibody (PTPRU/7616) [PE]
Immunogen
Recombinant fragment (around aa1-200) of human PTP pi/PTPRU protein (exact sequence is proprietary)
Localization
Cell junction. Cell membrane. Single-pass type I membrane protein.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2 kappa
Applications for PTP pi/PTPRU Antibody (PTPRU/7616) [PE]
Application
Recommended Usage
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: PTP pi/PTPRU
Long Name
Receptor-type Protein Tyrosine Phosphatase pi
Alternate Names
FMI, GLEPP1, PCP-2, pi R-PTP-Psi, PTP-J, PTP-PI, PTPRO, PTPRU, R-PTP-U
Gene Symbol
PTPRU
Additional PTP pi/PTPRU Products
Product Documents for PTP pi/PTPRU Antibody (PTPRU/7616) [PE]
Product Specific Notices for PTP pi/PTPRU Antibody (PTPRU/7616) [PE]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...